Aurinia Pharmaceuticals Inc (AUPH)

R&D to Revenue

15.68%

Quarterly · Period ending:

AUPH logo

AUPH R&D to Revenue

Latest reported15.68%
AUPH Quarterly R&D/Revenue (0.00% → 15.68%)
High-resolution chart · PNG

AUPH r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
15.6813%
9.6133%
14.1284%
11.4812%
10.6159%
9.1939%
13.5417%
4.496%
7.1339%
11.0351%
22.681%
24.9564%
30.4863%
38.24%
34.7107%
19.6723%
40.8818%
58.3584%
47.6372%
136.8105%
152.432%
1,075.8206%
26.3302%
42,217.2414%
38,193.1034%
46,116.6667%
45,834.4828%
7,735.2174%
38,455.1724%
35,436.6667%
37,375.8621%
2,973.8667%
36,220.6897%
29,623.3333%
28,035.4839%
37,265.5172%
2,160.1824%
23,629.0323%
18,206.6667%
10,780.6452%
4,374.5455%
5,831.5789%
6,407.0175%
8,192.9825%
7,338.9831%
5,370.9677%
4,547.0588%
3,379.1667%
3,587.3239%
1,552.2388%
92.4847%
625.2917%
519.54%
379.7778%
3,829.9802%
644.1872%
907.7865%
13.8276%
783.2428%
138.919%
729.7317%
582.8392%
325.244%
254.7801%
68.6577%
96.0705%
130.4162%
179.2398%
224.3732%
296.2057%
1,170.0472%
108.9479%
711.6824%
659.413%
1,236.8092%
1,202.547%
1,923.8534%
931.4738%
738.8931%
965.3466%
514.2721%
312.5315%
-400.0149%
288.0976%
2,446.8115%
1,387.2399%
2,149.0618%
1,876.1368%
461.7649%
382.8716%
511.6825%
641.2047%
29.9033%
878.8658%
-1,201.3873%
63.7936%
89.9215%
151.5514%
331.6055%
515.4426%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.